CMS Readmission Reduction Requirements for Cardiac Procedures
- The CMS Hospital Readmissions Reduction Program (HRRP), established under Section 3025 of the Affordable Care Act and implemented beginning in fiscal year 2013, penalizes hospitals with excess readmission rates for specific conditions and procedures. Cardiac surgery is represented through two HRRP measures: coronary artery bypass graft (CABG) surgery and acute myocardial infarction (AMI). Hospitals with excess readmission ratios above 1.0 for these measures receive a payment reduction applied to all Medicare discharges, not only cardiac cases.
- Per CMS data published in the fiscal year 2025 HRRP summary, more than 2,500 hospitals received HRRP payment reductions. The maximum penalty is 3% of base Medicare DRG payments. For cardiac surgery programs with high CABG volume, even a 0.5% excess readmission ratio translates to substantial annual revenue exposure. Discharge planning quality is one of the modifiable factors that hospital quality improvement teams target when addressing HRRP performance.
- The 30-day readmission window used by HRRP includes all-cause readmissions, not only those directly related to the index cardiac procedure. This means that a readmission for uncontrolled hypertension, wound infection, or atrial fibrillation in the first 30 days counts against the hospital's CABG measure performance. Discharge instructions covering medication adherence, dietary restrictions, blood pressure monitoring, and arrhythmia warning signs all have a direct connection to preventing these non-procedure-specific readmissions.
- The Joint Commission has published Transition of Care performance measures, including TC-05 (discharge instructions for heart failure patients), which serves as a model for cardiac surgery discharge documentation standards. While TC-05 applies specifically to heart failure admissions, many accreditation surveyors and quality improvement professionals apply its framework (covering activity, diet, medications, follow-up, weight monitoring, and warning symptoms) to post-cardiac surgery discharge planning as a benchmark.
Anticoagulation and Medication Management at Cardiac Discharge
- Patients discharged after mechanical valve replacement require lifelong anticoagulation with warfarin. The discharge instruction must specify the target INR range (typically 2.5 to 3.5 for mechanical mitral valves and 2.0 to 3.0 for mechanical aortic valves, per American Heart Association and American College of Cardiology guidelines), the initial dose prescribed, the date and location of the first INR check, and the specific symptoms of over-anticoagulation and under-anticoagulation that require immediate contact with the care team.
- CABG patients are typically discharged on dual antiplatelet therapy, a statin, a beta-blocker, and an ACE inhibitor or ARB. For each medication, discharge instructions should state the name (brand and generic), the dose, the frequency, the indication, and any critical safety instructions. For aspirin plus a P2Y12 inhibitor such as clopidogrel, the instructions must communicate that neither agent should be stopped without consulting the prescribing provider, as premature discontinuation increases graft thrombosis risk.
- Patients prescribed amiodarone for post-operative atrial fibrillation require specific discharge counseling on thyroid monitoring, pulmonary toxicity symptoms, photosensitivity, and the expected duration of treatment. The loading dose and maintenance dose must be clearly distinguished in writing. Amiodarone's numerous drug interactions, particularly with warfarin, digoxin, and certain statins, require that the discharge summary flag these interactions explicitly rather than leaving identification to the patient or outpatient pharmacist.
- Diuretic management after cardiac surgery requires that patients receive clear instructions on the dose, the expected duration, and criteria for dose adjustment. Instructions should specify how often to check daily weight, what weight gain threshold to report (typically 2 pounds in one day or 5 pounds in one week, consistent with standard heart failure management thresholds), and which provider to contact. Patients who cannot weigh themselves daily require an alternative monitoring approach that should be identified and documented at discharge.
Sternotomy Precautions and Physical Recovery Documentation
- Sternal healing after median sternotomy requires approximately 6 to 8 weeks for bone union. During this period, patients are typically restricted from lifting more than 5 to 10 pounds, pushing or pulling heavy objects, and performing activities that place asymmetric load across the sternum, such as driving a vehicle with a steering wheel. These restrictions must be stated in concrete, measurable terms in discharge instructions rather than general phrases such as 'take it easy' or 'avoid heavy lifting.'
- Patients should receive written criteria for signs of sternal instability or wound infection, which are among the most serious early post-operative complications after open cardiac surgery. Signs to report include sternal clicking or motion with movement, purulent discharge from the incision, increasing redness or warmth along the incision, or fever above 101 degrees Fahrenheit. Mediastinitis, an infection of the mediastinal space following sternotomy, carries significant mortality risk and requires prompt identification to enable early treatment.
- Driving restrictions after cardiac surgery are not uniform and depend on both the sternotomy healing timeline and any functional limitations such as visual disturbances from medications or cognitive effects of the post-operative period. Many cardiac surgery programs advise against driving for 4 to 6 weeks after surgery. Discharge instructions should state the restriction duration, the expected date of the follow-up visit at which driving clearance may be reassessed, and the instruction that the patient must receive explicit clearance before resuming driving.
- Cardiac rehabilitation referral is a Class I recommendation per ACC and AHA guidelines for patients following CABG and for heart failure patients with reduced ejection fraction. The discharge summary should document the referral, the program name and contact information when available, and the expected start date. Patients who do not receive a rehabilitation referral and are not documented as having a contraindication are a gap in care that quality reviewers and malpractice experts have identified in post-cardiac surgery claims.
Warning Signs and Structured Follow-Up Requirements
- Post-cardiac surgery patients face several time-sensitive complications in the first 30 days. Discharge instructions should explicitly list: chest pain or pressure distinct from expected incisional discomfort, shortness of breath at rest or with minimal exertion, palpitations or heart racing, syncope or near-syncope, sudden neurologic changes such as weakness, numbness, or speech difficulty, leg swelling or calf pain, and fever above 101 degrees Fahrenheit. Each symptom should be paired with a specific action: call the surgical office, go to the nearest emergency department, or call 911.
- Post-pericardiotomy syndrome, an inflammatory condition following cardiac surgery, typically presents 2 to 4 weeks after the procedure with chest pain that worsens with lying flat, fever, and pleuritic pain. Because its presentation can mimic other serious post-operative complications, patients should be instructed to contact the surgical team for any chest pain occurring beyond the first week rather than attributing it to expected healing.
- The recommended follow-up schedule after open cardiac surgery typically includes a wound check at 7 to 10 days and a comprehensive post-operative visit at 4 to 6 weeks. The discharge instruction should confirm both appointments with dates, times, and provider names. If the 7-day wound check appointment is with a different provider than the surgeon, the instruction must identify both contacts clearly so the patient does not delay reporting wound concerns while waiting for the later appointment.
- Patients with post-operative new-onset atrial fibrillation who are discharged on rate control or rhythm control medications require clear instructions on when to seek monitoring between discharge and follow-up. Symptoms of rapid atrial fibrillation, including palpitations with lightheadedness or dyspnea, should prompt immediate contact with the care team rather than waiting for a scheduled visit. Patients prescribed an outpatient cardiac monitor such as a 30-day event monitor should receive written instructions on device use and symptom-triggered recording.